Ace the West Virginia MPJE 2026 – Pharmacist Pro Power-Up!

The correct reference for the guidance on customized patient medication packages, commonly known as "med paks," is indeed USP 661. This chapter discusses the specific requirements and standards that must be met to ensure the quality and safety of these individualized medication packages. USP 661 covers aspects such as packaging materials, the design of the medication packages, and necessary labeling, helping to ensure that patients receive their medications in a way that enhances adherence and minimizes the risk of medication errors.

Other options do not pertain to the guidance on med paks. USP 663 and 665 relate to testing methodologies and standards for plastic materials and containers, while USP 667 deals with standards for transdermal delivery systems. Hence, they do not provide any relevant information about customized patient medication packages. Understanding this distinction is crucial for ensuring that pharmacy professionals are aware of the specific guidelines applicable to patient-centered medication management.